語系:
繁體中文
English
說明(常見問題)
登入
回首頁
切換:
標籤
|
MARC模式
|
ISBD
Phase II clinical development of new...
~
SpringerLink (Online service)
Phase II clinical development of new drugs
紀錄類型:
書目-語言資料,印刷品 : Monograph/item
正題名/作者:
Phase II clinical development of new drugs/ by Naitee Ting ... [et al.].
其他作者:
Ting, Naitee.
出版者:
Singapore :Springer Singapore : : 2017.,
面頁冊數:
xvii, 241 p. :ill. (some col.), digital ; : 24 cm.;
Contained By:
Springer eBooks
標題:
Drugs - Testing. -
電子資源:
http://dx.doi.org/10.1007/978-981-10-4194-5
ISBN:
9789811041945
Phase II clinical development of new drugs
Phase II clinical development of new drugs
[electronic resource] /by Naitee Ting ... [et al.]. - Singapore :Springer Singapore :2017. - xvii, 241 p. :ill. (some col.), digital ;24 cm. - ICSA book series in statistics,2199-0980. - ICSA book series in statistics..
Chapter 1 Introduction -- Chapter 2 Concept of Alpha -- Chapter 3 Confirmation and Exploration -- Chapter 4 Design a Proof of Concept (PoC) Trial -- Chapter 5 Design of Dose-Ranging Trials -- Chapter 6 Combining PoC and Dose Ranging Trials -- Chapter 7 Risks of Inconclusiveness -- Chapter 8 Analysis of a PoC Study -- Chapter 9 Data Analysis for Dose-Ranging Trials with Continuous Outcome -- Chapter 10 Data Analysis of Dose-Ranging Trials for Binary Outcomes -- Chapter 11 Bayesian Methods -- Chapter 12 Overview of Phase III Clinical Trials.
This book focuses on how to appropriately plan and develop a Phase II program, and how to design Phase II clinical trials and analyze their data. It provides a comprehensive overview of the entire drug development process and highlights key questions that need to be addressed for the successful execution of Phase II, so as to increase its success in Phase III and for drug approval. Lastly it warns project team members of the common potential pitfalls and offers tips on how to avoid them.
ISBN: 9789811041945
Standard No.: 10.1007/978-981-10-4194-5doiSubjects--Topical Terms:
581825
Drugs
--Testing.
LC Class. No.: RM301.27
Dewey Class. No.: 615.580724
Phase II clinical development of new drugs
LDR
:02082nam a2200337 a 4500
001
884922
003
DE-He213
005
20170412095616.0
006
m d
007
cr nn 008maaau
008
180530s2017 si s 0 eng d
020
$a
9789811041945
$q
(electronic bk.)
020
$a
9789811041921
$q
(paper)
024
7
$a
10.1007/978-981-10-4194-5
$2
doi
035
$a
978-981-10-4194-5
040
$a
GP
$c
GP
041
0
$a
eng
050
4
$a
RM301.27
072
7
$a
PBT
$2
bicssc
072
7
$a
MBNS
$2
bicssc
072
7
$a
MED090000
$2
bisacsh
082
0 4
$a
615.580724
$2
23
090
$a
RM301.27
$b
.P536 2017
245
0 0
$a
Phase II clinical development of new drugs
$h
[electronic resource] /
$c
by Naitee Ting ... [et al.].
260
$a
Singapore :
$c
2017.
$b
Springer Singapore :
$b
Imprint: Springer,
300
$a
xvii, 241 p. :
$b
ill. (some col.), digital ;
$c
24 cm.
490
1
$a
ICSA book series in statistics,
$x
2199-0980
505
0
$a
Chapter 1 Introduction -- Chapter 2 Concept of Alpha -- Chapter 3 Confirmation and Exploration -- Chapter 4 Design a Proof of Concept (PoC) Trial -- Chapter 5 Design of Dose-Ranging Trials -- Chapter 6 Combining PoC and Dose Ranging Trials -- Chapter 7 Risks of Inconclusiveness -- Chapter 8 Analysis of a PoC Study -- Chapter 9 Data Analysis for Dose-Ranging Trials with Continuous Outcome -- Chapter 10 Data Analysis of Dose-Ranging Trials for Binary Outcomes -- Chapter 11 Bayesian Methods -- Chapter 12 Overview of Phase III Clinical Trials.
520
$a
This book focuses on how to appropriately plan and develop a Phase II program, and how to design Phase II clinical trials and analyze their data. It provides a comprehensive overview of the entire drug development process and highlights key questions that need to be addressed for the successful execution of Phase II, so as to increase its success in Phase III and for drug approval. Lastly it warns project team members of the common potential pitfalls and offers tips on how to avoid them.
650
0
$a
Drugs
$x
Testing.
$3
581825
650
0
$a
Drug development.
$3
581824
650
1 4
$a
Statistics.
$3
556824
650
2 4
$a
Statistics for Life Sciences, Medicine, Health Sciences.
$3
670172
650
2 4
$a
Pharmaceutical Sciences/Technology.
$3
768561
650
2 4
$a
Management.
$3
558618
700
1
$a
Ting, Naitee.
$3
1141736
710
2
$a
SpringerLink (Online service)
$3
593884
773
0
$t
Springer eBooks
830
0
$a
ICSA book series in statistics.
$3
1067975
856
4 0
$u
http://dx.doi.org/10.1007/978-981-10-4194-5
950
$a
Mathematics and Statistics (Springer-11649)
筆 0 讀者評論
多媒體
評論
新增評論
分享你的心得
Export
取書館別
處理中
...
變更密碼[密碼必須為2種組合(英文和數字)及長度為10碼以上]
登入